Delivery Order SPE2DB22D3501-SPE2DB25FXK61
Award Date 9/18/25
Potential Completion Date 9/19/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,072.25 delivery order to AmerisourceBergen Drug Corp for Pegasys 180 mcg/ml vials, with an ultimate completion date of September 15, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing for pharmaceutical supply fulfillment. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $3,990.37 to AmerisourceBergen Drug Corp for the supply of Pegasys 180 mcg/ml vials. This competitively awarded, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply transaction. The award represents a child...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,072.25 by the Defense Logistics Agency's Medical Supply Chain for the procurement of Pegasys 180 mcg/ml vials. This firm fixed-price, competitively awarded contract (no set-aside) was issued on September 10, 2025, with an ultimate completion date of September 11, 2025. The contractor, headquartered in Conshohocken, Pennsylvania, will perform work at its Corporate Office location. This delivery order represents a child award...
- The Defense Logistics Agency awarded a delivery order valued at $2,763.00 to AmerisourceBergen Drug Corp for Pegasys 180 mcg/mL vials, with an ultimate completion date of August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with the DLA. This delivery...
- The Defense Logistics Agency awarded a $3,106.71 firm fixed price delivery order to AmerisourceBergen Drug Corp for Pegasys 180 mcg/ml vials, with an ultimate completion date of August 6, 2025. This non-set-aside competitive award was issued on August 5, 2025, with performance to be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this order as...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency valued at $2,752.23 for Pegasys 180 mcg/0.5 mL syringes. The contract is non-set-aside and competitively awarded on a firm fixed price basis, with an ultimate completion date of September 17, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,752.23 to AmerisourceBergen Drug Corp for Pegasys 180 mcg/0.5 mL syringes on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price contract, which was not set aside for small business or other designated categories, represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,139.94 to AmerisourceBergen Drug Corp for Pegasys 180 mcg/mL vials, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the awardee's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, will deliver the...
- The Defense Logistics Agency awarded a $2,752.22 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes. This is a firm fixed price contract with an ultimate completion date of August 22, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will take place at the...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,726.23 to AmerisourceBergen Drug Corp for Pegasys 180 mcg/ml vials on June 2, 2025, with completion scheduled for June 3, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and represents a child contract under AmerisourceBergen's larger federal procurement relationship. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, the...